Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=104"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=104

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00004978-626f905e",
        "title": "rIL-2 vs No rIL-2: Number of Participants With Changes in Anti-retroviral Treatment (ART)",
        "summary": "1760 of 2071 against 1751 of 2040; risk difference -0.9 points, 95% interval -3.0 to 1.3; NCT00004978, An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy",
        "record": "/library/comparisons/NCT00004978-626f905e",
        "nct_id": "NCT00004978",
        "kind": "outcome",
        "participants": 4111,
        "risk_difference": {
          "value": -0.00850233381619181,
          "lower": -0.03009205273188961,
          "upper": 0.01310841184821555
        },
        "group_1": "1,760 of 2,071",
        "group_2": "1,751 of 2,040",
        "difference": "-0.9 points",
        "interval": "-3.0 to 1.3",
        "trial_title": "An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy"
      },
      {
        "id": "NCT00004978-6b954b86",
        "title": "rIL-2 vs No rIL-2: Number of Participants Who Died From Any Cause",
        "summary": "107 of 2071 against 116 of 2040; risk difference -0.5 points, 95% interval -1.9 to 0.9; NCT00004978, An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy",
        "record": "/library/comparisons/NCT00004978-6b954b86",
        "nct_id": "NCT00004978",
        "kind": "outcome",
        "participants": 4111,
        "risk_difference": {
          "value": -0.005196883195576638,
          "lower": -0.019167839918950394,
          "upper": 0.008708798015541674
        },
        "group_1": "107 of 2,071",
        "group_2": "116 of 2,040",
        "difference": "-0.5 points",
        "interval": "-1.9 to 0.9",
        "trial_title": "An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=105",
  "request_id": "efdY2l_4L_PciFNb"
}